HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

(VIP-neurotensin) hybrid antagonist

contains fractions of VIP peptide & neurotensin; 28 amino acid sequence given in first source; consists of an N-terminal sequence from neurotensin and the 22 C-terminal amino acids of vasoactive intestinal peptide (VIP); inhibits VIP receptor
Also Known As:
(Lys(1)-Pro(2,5)-Arg(3,4)-Tyr(6))VIP(7-28); Lys-Pro-Arg-Arg-Pro-Tyr-VIP(7-28); VIP Hybrid; VIP-NE hybrid antag; VIPhyb; lysyl-prolyl-arginyl-arginyl-prolyl-tyrosyl-VIP(7-28); neurotensin(6-11)VIP(7-28)
Networked: 14 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Experts

1. Gozes, I: 3 articles (12/2001 - 01/2000)
2. Fridkin, M: 3 articles (12/2001 - 01/2000)
3. Moody, T W: 3 articles (12/2001 - 01/2000)
4. Southerland, Lauren: 2 articles (03/2013 - 01/2013)
5. Hossain, Mohammad S: 2 articles (03/2013 - 01/2013)
6. Waller, Edmund K: 2 articles (03/2013 - 01/2013)
7. Li, Jian-Ming: 2 articles (03/2013 - 01/2013)
8. Moody, Terry W: 2 articles (01/2004 - 01/2003)
9. Jensen, Robert T: 2 articles (01/2004 - 01/2003)
10. Brenneman, D: 2 articles (12/2001 - 01/2000)

Related Diseases

1. Necrosis
2. Inflammation
3. Neoplasms (Cancer)
4. Lung Neoplasms (Lung Cancer)
5. Infection

Related Drugs and Biologics

1. Annexin A5
2. Cadherins (E-Cadherin)
3. Messenger RNA (mRNA)
4. Phosphotransferases (Kinase)
5. Chromatin
6. Adenosine Triphosphate (ATP)
7. galantide (M 15)
8. Vasoactive Intestinal Peptide Receptors (Vasoactive Intestinal Peptide Receptor)
9. Vasoactive Intestinal Peptide (VIP (Vasoactive Intestinal Peptide))
10. (VIP-neurotensin) hybrid antagonist

Related Therapies and Procedures

1. Homologous Transplantation (Allograft)
2. Heterologous Transplantation (Xenotransplantation)
3. Lasers (Laser)